Effects of α-Synuclein-Associated Post-Translational Modifications in Parkinson's Disease

ACS Chem Neurosci. 2021 Apr 7;12(7):1061-1071. doi: 10.1021/acschemneuro.1c00028. Epub 2021 Mar 26.

Abstract

α-Synuclein (α-syn), a small highly conserved presynaptic protein containing 140 amino acids, is thought to be the main pathological hallmark in related neurodegenerative disorders. Although the normal function of α-syn is closely involved in the regulation of vesicular neurotransmission in these diseases, the underlying mechanisms of post-translational modifications (PTMs) of α-syn in the pathogenesis of Parkinson's disease (PD) have not been fully characterized. The pathological accumulation of misfolded α-syn has a critical role in PD pathogenesis. Recent studies of factors contributing to α-syn-associated aggregation and misfolding have expanded our understanding of the PD disease process. In this Review, we summarize the structure and physiological function of α-syn, and we further highlight the major PTMs (namely phosphorylation, ubiquitination, nitration, acetylation, truncation, SUMOylation, and O-GlcNAcylation) of α-syn and the effects of these modifications on α-syn aggregation, which may elucidate mechanisms for PD pathogenesis and lay a theoretical foundation for clinical treatment of PD.

Keywords: Parkinson’s disease; neurodegenerative diseases; post-translational modifications; protein aggregation; protein misfolding; α-Synuclein.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Humans
  • Parkinson Disease*
  • Phosphorylation
  • Protein Processing, Post-Translational
  • Ubiquitination
  • alpha-Synuclein* / metabolism

Substances

  • SNCA protein, human
  • alpha-Synuclein